Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Goodwill (2016 - 2017)

Soleno Therapeutics (SLNO) has disclosed Goodwill for 3 consecutive years, with $718000.0 as the latest value for Q1 2017.

  • Quarterly Goodwill changed 0.0% to $718000.0 in Q1 2017 from the year-ago period, while the trailing twelve-month figure was $718000.0 through Mar 2017, changed 0.0% year-over-year, with the annual reading at $718000.0 for FY2016, 21.68% down from the prior year.
  • Goodwill for Q1 2017 was $718000.0 at Soleno Therapeutics, roughly flat from $718000.0 in the prior quarter.
  • The five-year high for Goodwill was $916807.0 in Q4 2015, with the low at $718000.0 in Q3 2015.
  • Average Goodwill over 3 years is $746401.0, with a median of $718000.0 recorded in 2015.
  • Peak annual rise in Goodwill hit 0.0% in 2016, while the deepest fall reached 21.68% in 2016.
  • Over 3 years, Goodwill stood at $916807.0 in 2015, then decreased by 21.68% to $718000.0 in 2016, then changed by 0.0% to $718000.0 in 2017.
  • According to Business Quant data, Goodwill over the past three periods came in at $718000.0, $718000.0, and $718000.0 for Q1 2017, Q4 2016, and Q3 2016 respectively.